Overview

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study will measure the effect of the agent tadalafil on glucose and insulin homeostasis in people with metabolic syndrome in the presence and absence of an ACE inhibitor.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Collaborator:
National Institutes of Health (NIH)
Treatments:
Ramipril
Tadalafil